Acquisition - March 30, 2026
Insilico Medicine and Lilly enter R&D collaboration
Insilico Medicine has announced a drug discovery collaboration with Eli Lilly and Company (Lilly) that uses Insilico’s AI engine to accelerate the discovery and development of novel therapeutics across multiple therapeutic areas.
Acquisition - March 10, 2026
ClinStorage acquired by Rubicon Healthcare Partners
ClinStorage has entered a partnership with Rubicon Healthcare Partners, which will become the company’s new majority owner.
Acquisition - March 6, 2026
Sectra acquires Oxipit
Sectra has entered into an agreement to acquire Oxipit, a Lithuanian company specializing in AI-based solutions for radiology.
Acquisition - February 12, 2026
Devyser acquires Cybergene
Devyser Diagnostics has entered into an agreement relating to the acquisition of 100 percent of the shares in Cybergene AB, a Swedish company within the Level Bio group.
Acquisition - February 9, 2026
Lilly to acquire Orna Therapeutics to advance cell therapies
Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell therapies that can treat underlying disease.
Acquisition - February 3, 2026
Nanologica acquires Nordic CDMO
Nanologica has acquired Ardena Södertälje AB, the API CDMO in Södertälje, from Ardena Sweden in an all‑share deal valued at approximately SEK 8.6 million.